Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Sy...(that further studies of the Company'spro...),Health
Navigation Links
Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
Date:12/4/2007
that further studies of the Company's product candidates are not positive, and the uncertainties inherent in scientific research, drug development, clinical trials and the regulatory approval process. You are encouraged to review other important risk factors relating to the Company on our web site at http://www.acurapharm.com under the link, "Company Risk Factors" and detailed in Company filings with the Securities and Exchange Commission. The Company is at development stage and may never have any products or technologies that generate revenue. Acura Pharmaceuticals, Inc. assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. Acura Pharmaceuticals, Inc. press releases may be reviewed at http://www.acurapharm.com.
'/>"/>
| SOURCE Acura Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion(R) (Abuse-Deterrent) Technology
2. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
8. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
9. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
10. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
11. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
Post Your Comments:
(Date:12/2/2009)... , , KNOXVILLE, Tenn., Dec. 2 /PRNewswir...s presence in Southwest Florida with the acquisiti... LLC (EPN). Since January 2002, EPN has held an e...aff the emergency facilities at the Downtown Naple...ealthcare Clinic. EPN also provides the staffing f...
(Date:12/2/2009)... , Waltham, MAJoseph Balboni loves sports. An avi...n, the 46-year-old insurance agent became increasi...ue to keratoconus, a degenerative eye disorder. Un... Red Sox games, he faced the prospect of a corneal... , Then three years ago, Balboni discovered an a...
(Date:12/2/2009)... , EUROECHO 2009 is the official congress of the ...registered branch of the European Society of Cardi... imaging will be presented. , New case reports ...e latest evidence highlighting the role of this ne...t in imaging techniques, it is likely that non-inv...
(Date:12/2/2009)... , National Pen ( www.pen...retailer, announced today it is giving away 10,000... (PRWEB) December 2, 2009 -- National Pen ( www....ts retailer announced today it is giving away 10,0...ve a new way to promote business that no other com...
(Date:12/2/2009)... , Revolutionary new cell... away from users will be available in early 2010 f... (PRWEB) December 2, 2009 -- Revolutionary ...missions away from users will be available in earl...gy was recently honored with a Green Technology Aw...
Breaking Medicine News(10 mins):Health News:TeamHealth Acquires Emergency Physicians of Naples, LLC 2Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:Media alert: EUROECHO 2009 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2...,s revised statistics regarding new HIV infections...://www.requestatest.com/ [HIV testing __title__ H...ons infected don,t know they carry the HIV virus. ...decade. This was the surprising announcement made ...
...rma, Inc.,(Amex: DDD ) announced today that it ha... Abbreviated New Drug Application (ANDA) for a 120... the Company,s patented,Controlled Delivery Techno...ra(R) D, Sudafed(R),PSE, Claritin(R) D, Zyrtec(R) ...
...Technology Investments Streamline Processes, Acc...dy, NASHVILLE, Tenn., Aug. 5 HealthLeaders-Inter...ntelligence, reports that Health,Care Service Corp...lue Profiler: Health Care Service Corporation, the...
...,Therapeutics (Nasdaq: NKTR ) today announced the... the position of Senior Vice President of Drug,Dev...ugust 11, 2008. Dr.,Moreadith will report to Nekta...and Regulatory Affairs at Nektar. He is,responsibl...
...aceutical,Services, Inc. (NYSE: WST ) today annou...ef Financial Officer, and Michael Anderson, Vice P...vices, Inc., will be presenting at,the CJS Securit... conference will be available through the Investor...
...y-stage patients who don,t yet need dialysis, stud...ws) -- Monitoring levels of a hormone called fibro...reatment of kidney failure patients, say Massachus...s were much more likely to die within the first ye...
Other Medicine News:Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 2Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 3Health News:SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation 2Health News:SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation 3Health News:Insurance Giant Leverages Technology to Enhance Offerings 2Health News:Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer 2Health News:Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer 3Health News:Monitoring Hormone May Improve Kidney Failure Outcomes 2Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates"SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine FormulationInsurance Giant Leverages Technology to Enhance OfferingsNektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development OfficerWest Pharmaceutical Services to Present at the CJS Securities Investor ConferenceMonitoring Hormone May Improve Kidney Failure Outcomes
(Date:12/1/2009)...c. 1 Reportlinker.com announces th...s catalogue: ,, HPLC Systems & Accessories...linker.com/p0164366/HPLC-Systems--Accessories---A-...quid Chromatography has emerged as a workhorse tec...d beverage, research and development, and industri...
(Date:12/1/2009)...sh., Dec. 1 drugstore.co...r of health, beauty, vision, and pharmacy products...ay ever as customer orders were the highest in com...om and Beauty.com web stores featured more spec...t gift selection yet. ,, (Logo: http://www.new...
(Date:12/1/2009).... 1 Reportlinker.com announces tha... catalogue: ,, Molecular Diagnostics - A World.../p0164231/Molecular-Diagnostics---A-World-Market-R...being driven by several growth factors that includ...ques, which combine optimized sample preparation, ...
Breaking Medicine Technology:Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6Reportlinker Adds Molecular Diagnostics - A World Market Review 7VHA Citizenship and Sustainability Scorecard Shows Progress in the Health Care Networks Earth Friendly Business Practices 49900 1VHA Citizenship and Sustainability Scorecard Shows Progress in the Health Care Networks Earth Friendly Business Practices 49900 2VHA Citizenship and Sustainability Scorecard Shows Progress in the Health Care Networks Earth Friendly Business Practices 49900 3Diabetes 3A Its Connection to Oral Health 49895 1Diabetes 3A Its Connection to Oral Health 49895 2Diabetes 3A Its Connection to Oral Health 49895 3Veran Medical Enables Breakthrough 4D Navigation to Cancer Lesions at University of Virginia Hospital 49893 1Veran Medical Enables Breakthrough 4D Navigation to Cancer Lesions at University of Virginia Hospital 49893 2...Study Showed Larazotide Acetate Prevented Immunolo...atients with Celiac Disease, Additional Data Indic...ase, ORLANDO, Fla., Oct. 7 Alba Therapeutics Cor...es this week at the American,College of Gastroente...from,study CLIN 1001-004, the first Phase IIa tria...
...FORT COLLINS, Colo., Oct. 7 A study published in ...stem cell self-renewal,reported that InVitria,s ( ...uman serum albumin) was an effective replacement t...rticle entitled, "The ground state of embryonic st...used Cellastim as a recombinant,albumin in place o...
Other Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Blue Line® Intubation Stylet 7.5 mm 10 mm
Blue Line® Intubation Stylet 2.5 mm 4.5 mm
Surch-Lite™ Flexible Light - 15" Sterile
Surch-Lite™ Flexible Light - 5" Non-Sterile
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |